IQVIA Holdings Inc.
IQVIA Holdings Inc. (IQV) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
iqv · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for IQVIA Holdings Inc. (IQV) measures how much investors pay for each dollar of the company's trailing earnings. IQV's current PE ratio of 22.16x is calculated by dividing its stock price of $182.38 by its TTM earnings per share of $8.22. −37.4% discount vs 5Y avg 35.4x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2010 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 16 fiscal years · Front-end computedMinQ1 · 25%30.5x
MedianQ3 · 75%157.8x
Max
At 22.16x, IQV's current P/E is lower than in 25% of its annual fiscal year readings over the past 16 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
IQVIA Holdings Inc.You IQV | $30.4B | 22.16x | -18.0% | $8.22 |
 Agilent Technologies, Inc. A | $37.6B | 31.79x | +17.7% | $4.60 |
 Alcon Inc. ALC | $32.3B | 39.80x | +47.3% | $1.98 |
 Cardinal Health, Inc. CAH | $48.1B | 25.94x | -4.0% | $6.48 |
 GE HealthCare Technologies Inc. GEHC | $29.4B | 17.97x | -33.5% | $4.56 |
 Haleon plc HLN | $39.7B | 20.62x | -23.7% | $0.36 |
 Humana Inc. HUM | $42.4B | 25.97x | -3.9% | $9.86 |
Industry Average 6 peers with valid PE | — | 27.01x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 28.49x | $7.91 | +9.8% | |
2024-12-31 FY2024 | 25.95x | $7.57 | -17.1% | |
2023-12-31 FY2023 | 31.32x | $7.39 | -11.1% | |
2022-12-31 FY2022 | 35.23x | $5.82 | -37.0% | |
2021-12-31 FY2021 | 55.90x | $5.05 | -54.5% | |
2020-12-31 FY2020 | 122.85x | $1.46 | -22.2% | |
2019-12-31 FY2019 | 157.83x | $0.98 | +72.7% | |
2018-12-31 FY2018 | 91.37x | $1.27 | +460.9% | |
2017-12-31 FY2017 | 16.29x | $6.01 | -83.5% | |
2016-12-31 FY2016 | 98.60x | $0.77 | +351.9% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for IQVIA Holdings Inc. (IQV) measures how much investors pay for each dollar of the company's trailing earnings. IQV's current PE ratio of 22.16x is calculated by dividing its stock price of $182.38 by its TTM earnings per share of $8.22.
Frequently asked questions
IQV pe ratio · 6 questionsIQV's current PE ratio is 22.16x as of 2026-06-08, based on a stock price of $182.38 and TTM EPS of $8.22. Data sourced from Financial Modeling Prep via IQV's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IQVIA Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08